
The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …

Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …

The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …

A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …

The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …

AstraZeneca and MSD’s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for the …

Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall of M&A Pharmachem’s 500mg paracetamol tablets. The …

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona. The new …

The WHO has decided not to declare the Ebola crisis in the Congo a global emergency. While the WHO said …

Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …

A person has died after experiencing an adverse event related to a faecal transplant. The FDA has warned that two …

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …

Gilead has entered into an agreement with Canadian monoclonal antibody discovery firm AbCellera. The two firms will take part in …